Gosuranemab (BMS-986168, IPN007) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab neutralizes the extracellular tau protein, inhibiting the spread and aggregation of pathological tau protein. Gosuranemab can be used for the researches of alzheimers disease (AD) and progressive supranuclear palsy (PSP)[1][2].
Molekulargewicht:
(144.94 kDa)
Reinheit:
97.31
CAS Nummer:
[1788032-39-2]
Target-Kategorie:
Tau Protein
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten